Skip to main content

Table 1 Alteration of the risk factors used for the calculation of Framingham Risk Score in 35 eligible studies compared to the Framingham Risk Score 1998, 2002 and 2008

From: A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification

 

No. of Studies (n = 35)

Ordinal outcomes

Items of Alteration (n = 18)

Yes

No

Unclear

Addition

   

Item 1. Antihypertensive

16

15

4

Item 2. Weight related measures, e.g. BMI

0

35

0

Item 3. Race/ethnic groups

2

33

0

Item 4. Triglycerides

2

33

0

Item 5. Alcohol

0

35

0

Item 6. Previous cardiovascular disease

1

34

0

Item 7. Others (family history, PVD & stroke)

5

30

0

Deletion

   

Item 8. Diastolic blood pressure

9

21

5

Item 9. aDiabetes

0

19

0

Item 10. HDL cholesterol

4

28

3

Modification

   

Blood pressure

   

Item 11. Systolic blood pressure

3

23

9

Item 12. History of hypertension/self-reported hypertension

7

23

5

Item 13. Other blood pressure definition modification

3

31

1

Lipid levels

   

Item 14. History of hyperlipidaemia/ self-reported hyperlipidaemia

14

14

7

Diabetes

   

Item 15. aFasting glucose > 126 mg/dL or 7.8 mmol/L

0

19

0

Item 16. aSelf-reported diabetes/ use diabetic medication

3

10

6

Smoking

   

Item 17. Pack years of smoking

0

34

1

Item 18. Use of ex-smoker category

11

23

1

  1. Abbreviations: BMI body mass index, HDL high density lipoprotein, PVD peripheral vascular disease
  2. a13 studies used FRS 2002 and 3 studies used FRS 2008 and diabetes related items were discounted